Chemo

Chemo is a part of the Insud Pharma group and has been in operation since 1977. The company is driven by a commitment to global affinity in healthcare and operates across the entire pharmaceutical value chain. With a focus on scientific research, development, manufacturing, sales, and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals for human and animal health, Chemo has established its main offices in Madrid, Lugano, and Buenos Aires, although its operations span Europe, America, Asia, and Africa. The company aims to address global opportunities and customers'​ needs in all major pharmaceutical markets while emphasizing innovation and sustainable development. Chemo's core belief is centered on improving people's health and quality of life by providing access to quality medicines at affordable prices, and the continuous expansion of efforts and R&D investment to develop new and better therapies. Despite not having a current record of last investment or specific last investment investors available, the company's emphasis on global reach, innovation, and commitment to improving healthcare accessibility and affordability positions it as a notable player in the manufacturing and pharmaceutical industries.